RESUMEN
Base excision is a crucial DNA repair process mediated by endonuclease IV in nucleotide excision. In Chlamydia pneumoniae, CpendoIV is the exclusive AP endonuclease IV, exhibiting DNA replication error-proofreading capabilities, making it a promising target for anti-chlamydial drug development. Predicting the structure of CpendoIV, molecular docking with DNA was performed, analyzing complex binding sites and protein surface electrostatic potential. Comparative structural studies were conducted with E. coli EndoIV and DNA complex containing AP sites.CpendoIV was cloned, expressed in E. coli, and purified via Ni-NTA chelation and size-exclusion chromatography. Low NaCl concentrations induced aggregation during purification, while high concentrations enhanced purity.CpendoIV recognizes and cleaving AP sites on dsDNA, and Zn2+ influences the activity. Crystallization was achieved under 8% (v/v) Tacsimate pH 5.2, 25% (w/v) polyethylene glycol 3350, and 1.91 Å resolution X-ray diffraction data was obtained at 100 K. This research is significant for provides a deeper understanding of CpendoIV involvement in the base excision repair process, offering insights into Chlamydia pneumoniae.
Asunto(s)
Proteínas Bacterianas , Chlamydophila pneumoniae , Cristalización , Chlamydophila pneumoniae/enzimología , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/química , Cristalografía por Rayos X , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Proteínas Bacterianas/aislamiento & purificación , Escherichia coli/genética , Simulación del Acoplamiento Molecular , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Desoxirribonucleasa IV (Fago T4-Inducido)/química , Desoxirribonucleasa IV (Fago T4-Inducido)/genética , Desoxirribonucleasa IV (Fago T4-Inducido)/metabolismo , Desoxirribonucleasa IV (Fago T4-Inducido)/aislamiento & purificación , Clonación MolecularRESUMEN
Chlamydophila pneumoniae is a cause of community-acquired pneumonia (CAP) and responsible for 1-2% of cases in paediatric patients. In Mexico, information on this microorganism is limited. The aim of this study was to detect C. pneumoniae using two genomic targets in a real-time PCR and IgM/IgG serology assays in paediatric patients with CAP at a tertiary care hospital in Mexico City and to describe their clinical characteristics, radiological features, and outcomes. A total of 154 hospitalized patients with diagnosis of CAP were included. Detection of C. pneumoniae was performed by real-time PCR of the pst and arg genes. Complete blood cell count, C-reactive protein measurement and IgM and IgG detection were performed. Clinical-epidemiological and radiological data from the patients were collected. C. pneumoniae was detected in 25 patients (16%), of whom 88% had underlying disease (P = 0.014). Forty-eight percent of the cases occurred in spring, 36% in girls, and 40% in children older than 6 years. All patients had cough, and 88% had fever. Interstitial pattern on chest-X-ray was the most frequent (68%), consolidation was observed in 32% (P = 0.002). IgM was positive in 7% and IgG in 28.6%. Thirty-six percent presented complications. Four percent died. A high proportion showed co-infection with Mycoplasma pneumoniae (64%). This is the first clinical report of C. pneumoniae as a cause of CAP in Mexican paediatric patients, using two genomic target strategy and serology. We found a frequency of 16.2% with predominance in children under 6 years of age. In addition; cough and fever were the most common symptoms. Early detection of this pathogen allows timely initiation of specific antimicrobial therapy to reduce development of complications. This study is one of the few to describe the presence of C. pneumoniae in patients with underlying diseases.
Asunto(s)
Chlamydophila pneumoniae , Infecciones Comunitarias Adquiridas , Neumonía por Mycoplasma , Femenino , Niño , Humanos , Preescolar , Neumonía por Mycoplasma/complicaciones , Neumonía por Mycoplasma/diagnóstico , Neumonía por Mycoplasma/epidemiología , Chlamydophila pneumoniae/genética , Patología Molecular , Tos , México/epidemiología , Centros de Atención Terciaria , Mycoplasma pneumoniae/genética , Infecciones Comunitarias Adquiridas/diagnóstico , Infecciones Comunitarias Adquiridas/epidemiología , Inmunoglobulina G , Inmunoglobulina MRESUMEN
The aim of the study was to develop an algorithm for the selection of discriminating probes to identify a wide range of causative agents of human infectious diseases. Materials and Methods: The algorithm for selecting the probes was implemented in the form of the disprose (DIScrimination PRObe SElection) computer program written in the R language. Additionally, third-party software was used: the BLAST+ and ViennaRNA Package programs. The developed algorithm was tested by selecting specific probes for detecting Chlamydophila (Chlamydia) pneumoniae - an atypical bacterial pathogen causing community-acquired pneumonia (CAP). Nucleotide sequences for analysis were downloaded from the NCBI databank. Results: An algorithm for the selection of specific probes capable of detecting human infectious pathogens has been developed. The algorithm is implemented in the form of the disprose modular program, which allows for performing all stages of the probe selection process: loading the nucleotide sequences and their metadata from available databanks, creating local databases, forming a pool of probes, calculating their physicochemical parameters, aligning the probes and sequences contained in local databases, processing and evaluating the alignment results. The algorithm was successfully tested and its performance was confirmed by selecting a set of probes for the specific detection of Chlamydophila pneumoniae. The specificity of the selected probes calculated in silico indicated a low risk of their nonspecific binding and a high potential of using them as molecular genetic diagnostic tools (DNA microarrays, PCR). Conclusion: An algorithm for the selection of specific probes detecting a wide range of human pathogens in clinical biomaterial has been developed and implemented in the form of the disprose modular program. The probes selected using this program can serve as the functional basis of DNA-oriented microarrays able to identify causative agents of polyetiological diseases, such as CAP. Due to the flexibility and openness of the program, the scope of its application can be expanded.
Asunto(s)
Chlamydophila pneumoniae , Infecciones Comunitarias Adquiridas , Algoritmos , Chlamydophila pneumoniae/genética , Infecciones Comunitarias Adquiridas/diagnóstico , Humanos , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , TecnologíaRESUMEN
Acute respiratory infections are widespread in vulnerable populations of all ages and are characterized by a variety of symptoms. The underlying infection can be caused by a multitude of microorganisms, including viruses and bacteria. Early detection of respiratory infections through rapid pathogen screening is vital in averting infectious respiratory disease epidemics. This study utilized a multiplex real-time PCR system to develop a three-tube reverse transcription-PCR (RT-PCR) assay, enabling simultaneously detect nine respiratory pathogens, including: influenza A and B, adenovirus, respiratory syncytial virus (RSV), Streptococcus pneumoniae, Legionella pneumophila, Haemophilus influenzae, Chlamydia pneumoniae, and Mycoplasma pneumoniae. This technique utilizes a one-step assay, with specifically designed TaqMan primer-probe sets combined in the same tube. This assay provided rapid and simplified detection of the nine prevalent pathogens, as well as increased sensitivity and reduced cross-contamination. This assay was evaluated using 25 related viral/bacterial strains as positive references, the other 25 irrelevant strains as negative controls, and clinical specimens from 179 patients. All positive strains were detected with no amplification of the non-target microorganism mixtures and the assay's detection limits ranged between 250-500 copies/ml (1.25-2.5 copies/reaction). A total of 167 (93.3%) samples tested positive for at least one of the pathogens identified; 109 of these samples were from patients confirmed to have RSV infections. The diagnostic accuracy of our assay was further confirmed by matching results from classical direct immunofluorescence assay and nucleotide sequencing. These data demonstrate the innovative multiplex real-time PCR assay as a promising alternative to the current approaches used for early screening of acute respiratory infections.
Asunto(s)
Chlamydophila pneumoniae , Virus Sincitial Respiratorio Humano , Infecciones del Sistema Respiratorio , Virus , Chlamydophila pneumoniae/genética , Humanos , Reacción en Cadena de la Polimerasa Multiplex/métodos , Reacción en Cadena en Tiempo Real de la Polimerasa , Sensibilidad y Especificidad , Virus/genéticaRESUMEN
Objective: To analyze the epidemiological characteristics of Chlamydia pneumoniae infection among patients with acute respiratory infection in Beijing from 2015 to 2019. Methods: The epidemiological data of acute respiratory infection patients from 35 sentinel hospitals in Beijing were collected by the respiratory pathogen surveillance system in Beijing. The clinical samples were collected to detect Chlamydia pneumoniae, and the sequence of the VD4 region of the ompA gene in positive samples was analyzed. Results: From January 2015 to December 2019, the overall positive rate of Chlamydia pneumoniae among patients with acute respiratory infection in Beijing was 0.34% (129/37 460). The positive rate of Chlamydia pneumoniae generally increased in March, reaching the peak in May, and started to drop in July, with a duration of about 5-8 months. The epidemic season in different years fluctuated by 1-2 months. The positive monthly rate of Chlamydia pneumoniae was no less than 0.30% in every epidemic season. The positive rate of Chlamydia pneumoniae was the highest in the 5-44 years old group and the highest in 10-14 year-olds. The risk of Chlamydia pneumoniae infection increased with age in patients younger than 25 years old and decreased in those older one aged than 25 years of age. The positive rates in male and female patients were 0.33% (68/20 830) and 0.37% (61/16 528), respectively, and there was no significant difference between the two groups (χ2=0.486, P=0.486). The positive rate of Chlamydia pneumoniae in patients with common pneumonia was higher than that in patients with upper pneumonia and severe pneumonia (χ2=36.797, P<0.01). Other respiratory pathogens were also detected in the Chlamydia pneumoniae samples, and the top four pathogens appeared as Haemophilus influenzae (15 cases), Streptococcus pneumoniae (13 cases), Rhinovirus (8 cases), and Stenotrophomonas maltophilia (7 cases). 101 strains of 129 Chlamydia pneumoniae positive samples were identified as type A by sequencing. Conclusions: The annual epidemic pattern of Chlamydia pneumoniae in Beijing, is unimodal, and the epidemic season generally appears from March to July. The seasonal characteristics of Chlamydia pneumoniae in Beijing can be used for the differential diagnosis of Chlamydia pneumoniae from other respiratory pathogens. Chlamydia pneumoniae is most common in people aged 5-44 years, and the primary genotype is type A. People aged 10-44 years old suffer the highest incidence. If the nucleic acid positive rate of Chlamydia pneumoniae exceeds 0.30% for two consecutive months, the high prevalence period of Chlamydia pneumoniae can be preliminarily expected. Chlamydia pneumoniae infection has a higher probability of progressing to severe pneumonia from general pneumonia.
Asunto(s)
Chlamydophila pneumoniae , Neumonía , Infecciones del Sistema Respiratorio , Adolescente , Adulto , Niño , Preescolar , Chlamydophila pneumoniae/genética , Femenino , Humanos , Masculino , Mycoplasma pneumoniae , Infecciones del Sistema Respiratorio/epidemiología , Rhinovirus , Adulto JovenRESUMEN
Chlamydia abortus (C. abortus) is one of the most important zoonotic pathogens, causing a number of serious diseases. The adhesion of C. abortus to host cells is the first and crucial step in the process of infection. Outer membrane protein 2 (OmcB) is the second most abundant outer membrane protein. It has been shown to be an important adhesin of Chlamydia trachomatis and Chlamydia pneumoniae. In the present study, the OmcB gene of C. abortus was cloned and expressed in Escherichia coli, and the recombinant OmcB protein with His-tag was used to prepare polyclonal antibodies. Infectivity inhibition assays carried out with C. abortus in the presence of recombinant OmcB showed a considerable reduction (â¼50%) in infectivity. Using anti-OmcB serum in infectivity inhibition assays resulted in a 30% reduction in infectivity. Anti-OmcB serum and recombinant OmcB protein in infection inhibition assays showed that OmcB is a surface-exposed protein that functions as an adhesin. The constructed deletion variant of the OmcB motif for infection inhibition assays showed that the first XBBXBX motif of the C. abortus OmcB protein is essential for binding to host cells.
Asunto(s)
Proteínas de la Membrana Bacteriana Externa , Chlamydophila pneumoniae , Adhesinas Bacterianas/genética , Proteínas de la Membrana Bacteriana Externa/genética , Chlamydia , Chlamydia trachomatis/genética , Chlamydophila pneumoniae/genéticaRESUMEN
Early detection of the family Chlamydiaceae as pathogens is essential worldwide for the rapid and sufficient management of atypical pneumonia. GENECUBE (TOYOBO) is a novel fully automated gene analyzer capable of amplifying and detecting target DNAs within 50 min. In this study, we developed a new PCR assay with a specific quenching probe (PCR-QC assay) for rapidly distinguishing between Chlamydia pneumoniae (CPN) and Chlamydia psittaci (CPS). The PCR-QC assay enabled us to precisely and simultaneously detect the 2 different types of DNA fragments even in a mixed sample by identifying unique melting temperatures. Next, we examined a total of 300 frozen samples from patients with respiratory tract infection using the PCR-QC assay and the cell culture method as the gold standard. Kappa index for agreement between the PCR-QC assay and the culture method was 0.43 (95% confidential interval (CI): 0.08-0.78). The sensitivity and specificity of the PCR-QC assay were 36.3% (4/11; 95% CI: 10.9-69.2%)) and 99.0% (286/289; 95% CI: 97.0-99.8%), respectively. The samples positive for CPN (n = 13) or CPS (n = 1) by either method were also examined by a conventional PCR TaqMan assay, which produced the same results as those from the PCR-QC assay. Furthermore, the PCR-QC assay using GENECUBE shortened the full detection time for CPN or CPS (within 50 min vs. more than 2 to 3 h) compared with conventional PCR TaqMan assays. Therefore, the new PCR-QC assay system equipped with GENECUBE is useful for rapidly detecting CPN or CPS pathogens in clinical laboratory, and may improve the management of atypical pneumonia.
Asunto(s)
Chlamydophila pneumoniae/aislamiento & purificación , Chlamydophila psittaci/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Infecciones por Chlamydia/microbiología , Chlamydophila pneumoniae/genética , Chlamydophila psittaci/genética , ADN Bacteriano/química , ADN Bacteriano/genética , Análisis Discriminante , Humanos , Sensibilidad y Especificidad , Temperatura de TransiciónRESUMEN
OBJECTIVES: The contribution of intracellular and fastidious bacteria in Cystic fibrosis (CF) pulmonary exacerbations, and progressive lung function decline remains unknown. This project aimed to explore their impact on bacterial microbiota diversity over time in CF children. METHODS: Sixty-one children enrolled in the MUCOVIB multicentre prospective cohort provided 746 samples, mostly nasopharyngeal swabs, throat swabs and sputa which were analysed using culture, specific real-time qPCRs and 16S rRNA amplicon metagenomics. RESULTS: Chlamydia pneumoniae (n = 3) and Mycoplasma pneumoniae (n = 1) were prospectively documented in 6.6% of CF children. Microbiota alpha-diversity in children with a documented C. pneumoniae was highly variable, similarly to children infected with Staphylococcus aureus or Pseudomonas aeruginosa. The transition from routine follow-up visits to pulmonary exacerbation (n = 17) yielded variable changes in diversity indexes with some extreme loss of diversity. CONCLUSIONS: The high rate of C. pneumoniae detection supports the need for regular screenings in CF patients. A minor impact of C. pneumoniae on the microbial community structure was documented. Although detected in a single patient, M. pneumoniae should also be considered as a possible aetiology of lung infection in CF subjects.
Asunto(s)
Chlamydophila pneumoniae/aislamiento & purificación , Fibrosis Quística/microbiología , Microbiota , Mycoplasma pneumoniae/aislamiento & purificación , Sistema Respiratorio/microbiología , Biodiversidad , Niño , Preescolar , Infecciones por Chlamydophila/microbiología , Chlamydophila pneumoniae/genética , ADN Bacteriano , Humanos , Metagenómica , Mycoplasma pneumoniae/genética , Neumonía por Mycoplasma/microbiología , Estudios Prospectivos , ARN Ribosómico 16S , Esputo/microbiologíaRESUMEN
FONAMENT: Mycoplasma pneumoniae I Chlamydophila pneu-moniae són agents causals freqüents de la pneumònia adquirida a la comunitat (PAC) en pediatria, I les tècniques com la reacció en cadena de la polimerasa (PCR) poden facilitar-ne el diagnòstic etiològic precoç, adequant l'antibioteràpia emprada. OBJECTIU: Descriure l'ús d'aquesta tècnica en el maneig ambulatori dels pacients pediàtrics amb PAC que acudeixen a urgències. MÈTODE: Estudi observacional, retrospectiu I descriptiu de pacients pediàtrics diagnosticats de PAC a urgències amb maneig ambulatori. RESULTATS: De 67 pacients, el 32,8% va obtenir un resultat positiu per a bacteris atípics. El percentatge de resultats positius en <4 anys va ser del 10,0% I en ≥4 anys del 42,6% (p = 0,021). Van rebre antibiòtic empíric a l'alta 49 pacients dels 67 (73,1%): 31 macròlids, 12 betalactàmics I 6 ambdós. Amb el resultat de la PCR, per resultat negatiu es van retirar els macròlids a 25 dels 37 als quals se'ls havia pautat (67,6%) I es va pautar a 10 dels 22 casos positius que no els estaven rebent (45,5%). CONCLUSIONS: La PCR de bacteris atípics facilita el diagnòstic microbiològic ràpid I l'adequació de l'antibioteràpia, i, sobretot, evita l'excés de tractament amb macròlids a les urgències pediàtriques
FUNDAMENTO: Mycoplasma pneumoniae y Chlamydophila pneumoniae son agentes causales frecuentes de la neumonía adquirida en la comunidad (NAC) en pediatría, y las técnicas como la reacción en cadena de la polimerasa (PCR) pueden facilitar su diagnóstico etiológico precoz, adecuando la antibioterapia utilizada. OBJETIVO: Describir el uso de esta técnica en el manejo ambulatorio de los pacientes pediátricos con NAC que acuden a urgencias. MÉTODO: Estudio observacional, retrospectivo y descriptivo de pacientes pediátricos diagnosticados de NAC en urgencias manejados ambulatoriamente. RESULTADOS: De 67 pacientes, el 32,8% obtuvo resultado positivo para bacterias atípicas. El porcentaje de resultados positivos en <4 años fue del 10,0% y en ≥4 años de 42,6% (p = 0,021). Recibieron antibiótico empírico 49 pacientes de los 67 (73,1%): 31 macrólidos, 12 betalactámicos y 6 ambos. Con el resultado de la PCR, por resultado negativo se retiraron los macrólidos a 25 de los 37 a los que se les había pautado (67,6%) y se pautó a 10 de los 22 casos positivos que no los estaban recibiendo (45,5%). CONCLUSIONES: La PCR de bacterias atípicas facilita el diagnóstico microbiológico rápido y la adecuación de la antibioterapia, evitando sobre todo el exceso de tratamiento con macrólidos en urgencias
BACKGROUND: Mycoplasma pneumoniae and Chlamydophila pneu-moniae are frequent causative agents of community-acquired pneumonia (CAP) in children. Techniques such as the polymerase chain reaction (PCR) can facilitate early diagnosis and adequacy of antibiotic therapy. OBJECTIVE: To describe the use of this test in the ambulatory management of children with CAP seen in the emergency room. METHOD: Observational, retrospective and descriptive study of children diagnosed with CAP in the emergency room and managed as outpatients. RESULTS: Sixty-seven patients were recruited and 22 (32.8%) had a positive PCR for atypical bacteria. The percentage of positive results in children <4 years was 10.0% and it was 42.6% in children ≥4 years (p = 0.021). Forty-nine (73.1%) patients received antibiotic treatment: 31 received macrolides, 12 beta-lactams and 6 both. The results of the PCR test resulted in discontinuation of macrolide treatment in 25 of 37 patients (67.6%) after a negative PCR test and in its prescription to 10 of the 22 (45.5%) positive cases that were not receiving it. CONCLUSIONS: The use of PCR for atypical bacteria in the emergency department facilitates rapid microbiological diagnosis and the adequacy of antibiotic therapy, avoiding over-treatment with macrolides
Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Infecciones Comunitarias Adquiridas/microbiología , Servicios Médicos de Urgencia , Neumonía Bacteriana/microbiología , Reacción en Cadena de la Polimerasa , Mycoplasma pneumoniae/genética , Neumonía por Mycoplasma/diagnóstico , Chlamydophila pneumoniae/genética , Infecciones por Chlamydophila/diagnóstico , Estudios Retrospectivos , Estaciones del AñoRESUMEN
Chlamydia pneumoniae is an obligate intracellular pathogen that causes diseases of the upper and lower respiratory tract and is linked to a number of severe and chronic conditions. Here, we describe a large, C. pneumoniae-specific cluster of 13 genes (termed mbp1-13) that encode highly homologous chlamydial proteins sharing the capacity to bind to membranes. The gene cluster is localized on the chromosome between the highly diverse adhesin-encoding pmp genes pmp15 and pmp14. Comparison of human clinical isolates to the predicted ancestral koala isolate indicates that the cluster was acquired in the ancestor and was adapted / modified during evolution. SNPs and IN/DELs within the cluster are specific to isolates taken from different human tissues and show an ongoing adaptation. Most of the cluster proteins harbor one or two domains of unknown function (DUF575 and DUF562). During ectopic expression in human cells these DUF domains are crucial for the association of cluster proteins to the endo-membrane system. Especially DUF575 which harbors a predicted transmembrane domain is important for binding to the membrane, while presence of the DUF562 seems to be of regulatory function. For Mbp1, founding member of the cluster that exhibits a very limited sequence identity to the human Rab36 protein, we found a specific binding to vesicles carrying the early endosomal marker PtdIns(3)P and the endosomal Rab GTPases Rab11 and Rab14. This binding is dependent on a predicted transmembrane domain with an α-helical / ß-strand secondary structure, as the mutant version Mbp1mut, which lacks the ß-strand secondary structure, shows a reduced association to PtdIns(3)P-positive membranes carrying Rab11 and Rab14. Furthermore, we could not only show that Mbp1 associates with Rab36, but found this specific Rab protein to be recruited to the early C. pneumoniae inclusion. Detection of endogenous Mbp1 and Mbp4 reveal a colocalization to the chlamydial outer membrane protein Momp on EBs. The same colocalization pattern with Momp was observed when we ectopically expressed Mbp4 in C. trachomatis. Thus, we identified a C. pneumoniae-specific cluster of 13 membrane binding proteins (Mbps) localizing to the bacterial outer membrane system.
Asunto(s)
Chlamydophila pneumoniae , Proteínas de la Membrana Bacteriana Externa/genética , Chlamydia trachomatis/genética , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/metabolismo , Humanos , Cuerpos de Inclusión/metabolismo , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Familia de Multigenes , Proteínas de Unión al GTP rabRESUMEN
Multiple potential pathogens are frequently co-detected among children with lower respiratory tract infection (LRTI). Evidence indicates that Bordetella pertussis has an important role in the aetiology of LRTI. We aimed to study the association between B. pertussis and other respiratory pathogens in children hospitalised with severe LRTI, and to assess clinical relevance of co-detection. Nasopharyngeal (NP) swabs and induced sputa (IS) were tested with a B. pertussis specific PCR; additionally, IS was tested for other pathogens using a multiplex PCR. We included 454 children, median age 8 months (IQR 4-18), 31 (7%) of whom tested positive for B. pertussis. Children with B. pertussis had more bacterial pathogens detected (3 versus 2; P < 0.001). While B. pertussis showed no association with most pathogens, it was independently associated with Chlamydia pneumoniae, Mycoplasma pneumoniae and parainfluenza viruses with adjusted risk ratios of 4.01 (1.03-15.64), 4.17 (1.42-12.27) and 2.13 (1.03-4.55), respectively. There was a consistent increased risk of severe disease with B. pertussis. Patterns indicated even higher risks when B. pertussis was co-detected with any of the three organisms although not statistically significant. Improving vaccine coverage against B. pertussis would impact not only the incidence of pertussis but also that of severe LRTI generally.
Asunto(s)
Bordetella pertussis/aislamiento & purificación , Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/virología , Bordetella pertussis/genética , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/aislamiento & purificación , Femenino , Hospitalización , Humanos , Incidencia , Lactante , Masculino , Reacción en Cadena de la Polimerasa Multiplex/métodos , Mycoplasma pneumoniae/genética , Mycoplasma pneumoniae/aislamiento & purificación , Respirovirus/genética , Respirovirus/aislamiento & purificación , Esputo/microbiología , Tos Ferina/microbiologíaRESUMEN
Purpose: Mycoplasma pneumoniae (M. pneumoniae) and Chlamydophila pneumoniae (C. pneumoniae) play a significant role in children of all ages with lower respiratory tract infections (LRTIs). This study was conducted to detect M. pneumoniae and C. pneumoniae in children with community-acquired LRTIs employing serology, polymerase chain reaction (PCR) and nested PCR analysis. Material and Methods: This study included 75 children with acute LRTIs for detection of M. pneumoniae and C. pneumoniae. Blood was obtained for M. pneumoniae and C. pneumoniae antibodies and nasopharyngeal aspirates for M. pneumoniae PCR and C. pneumoniae nested PCR. Results: M. pneumoniae infection was positive in 9 (64.21%) children aged 2-6 months and in 5 (35.79%) aged 7 months-12 years, and this difference was statistically significant (P = 0.002). C. pneumoniae infection was comparable within the age group and statistically insignificant (P = 0.43). Clinical and radiological profiles of M. pneumoniae- and C. pneumoniae-positive and negative patients were numerically comparable. Serology and PCR together detected M. pneumoniae infection in 14 (18.6%) children. The sensitivity, specificity and positive and negative predictive values of serology were 77.78%, 92.42%, 58.33% and 96.83%, respectively. C. pneumoniae infection was positive in 11 (14.6%) children by serology and nested PCR with 50% sensitivity, 87.67% specificity, 10% positive predictive value and 98.46% negative predictive value. Conclusions: Our study confirms that M. pneumoniae and C. pneumoniae play a significant role in community-acquired LRTIs and a combination of serology and nested PCR is useful for its diagnosis.
Asunto(s)
Infecciones por Chlamydophila/diagnóstico , Chlamydophila pneumoniae , Infecciones Comunitarias Adquiridas/diagnóstico , Neumonía por Mycoplasma/diagnóstico , Infecciones del Sistema Respiratorio/diagnóstico , Anticuerpos Antibacterianos/sangre , Niño , Preescolar , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/inmunología , Chlamydophila pneumoniae/aislamiento & purificación , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Lactante , Masculino , Mycoplasma pneumoniae/genética , Mycoplasma pneumoniae/inmunología , Mycoplasma pneumoniae/aislamiento & purificación , Neumonía Bacteriana/diagnóstico , Reacción en Cadena de la Polimerasa , Sensibilidad y Especificidad , Pruebas SerológicasRESUMEN
BACKGROUND: Acute respiratory infections are a common disease in children with high mortality and morbidity. Multiple pathogens can cause acute respiratory infections. A 2-year survey of hospitalized children was conducted to understand the epidemic situation, seasonal spread of pathogens and the improvement of clinical diagnosis, treatment and prevention of disease in Huzhou, China. METHODS: From September 2017 to August 2019, 3121 nasopharyngeal swabs from hospitalized children with acute respiratory infections were collected, and real-time PCR was used to detect various pathogens. Then, pathogen profiles, frequency and seasonality were analyzed. RESULTS: Of the 3121 specimens, 14.45% (451/3121) were positive for at least one pathogen. Of the single-pathogen infections, RSV (45.61%, 182/399) was the most frequent pathogen, followed by PIVs (14.79%, 59/399), ADV (14.54%, 58/399), MP (10.78%, 43/399), and IAV (5.26%, 21/399). Of the 52 coinfections, RSV + PIVs viruses were predominantly identified and accounted for 40.38% (21/52) of cases. RSV was the most frequent pathogen in all four groups. The highest positive rate of the pathogens occurred in the winter (21.26%), followed by autumn (14.98%), the summer (14.11%) and the spring (12.25%). CONCLUSION: Viruses are the main pathogens in hospitalized children with acute respiratory infections in Huzhou city, Zhejiang Province, China. Among the pathogens, RSV had the highest detection rate, and MP is also a common pathogen among children with acute respiratory infections. This study provided a better understanding of the distribution of pathogens in children of different ages and seasons, which is conducive to the development of more reasonable treatment strategies and prevention and control measures.
Asunto(s)
Infecciones por Chlamydophila/epidemiología , Infecciones por Virus ADN/epidemiología , Virus ADN/patogenicidad , Neumonía por Mycoplasma/epidemiología , Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/virología , Enfermedad Aguda/epidemiología , Adolescente , Niño , Preescolar , China/epidemiología , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/patogenicidad , Coinfección/microbiología , Coinfección/virología , Virus ADN/genética , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Masculino , Mycoplasma pneumoniae/genética , Mycoplasma pneumoniae/patogenicidad , Infecciones por Virus Sincitial Respiratorio/epidemiología , Virus Sincitiales Respiratorios/genética , Virus Sincitiales Respiratorios/patogenicidad , Infecciones del Sistema Respiratorio/epidemiología , Estaciones del AñoRESUMEN
OBJECTIVE: Chlamydia pneumoniae and Mycoplasma pneumoniae are both common causes of atypical pneumonia. We conducted an annual national survey of Japanese children to screen them for C. pneumoniae infections during the M. pneumoniae epidemic season. METHODS: Nasopharyngeal swab specimens were collected from children aged 0-15 years with suspected acute lower respiratory tract infection due to atypical pathogens, at 85 medical facilities in Japan from June 2008 to March 2018. Specimens were tested for infection using real-time polymerase chain reaction assays. RESULTS: Of 5002 specimens tested, 1822 (36.5%) were positive for M. pneumoniae alone, 42 (0.8%) were positive for C. pneumoniae alone, and 20 (0.4%) were positive for both organisms. In children with C. pneumoniae infection, the median C. pneumoniae DNA copy number was higher in those with single infections than in those with M. pneumoniae coinfection (p = 0.08); however it did not differ significantly according to whether the children had received antibiotics prior to sample collection (p = 0.34). CONCLUSIONS: The prevalence of C. pneumoniae infection was substantially lower than that of M. pneumoniae infection during the study period. The change in prevalence of C. pneumoniae was not influenced by that of M. pneumoniae. Children with single C. pneumoniae infection are likely to have had C. pneumoniae infection, while those with coinfection are likely to have been C. pneumoniae carriers.
Asunto(s)
Infecciones por Chlamydia , Infecciones por Chlamydophila , Chlamydophila pneumoniae , Infecciones Comunitarias Adquiridas , Epidemias , Neumonía por Mycoplasma , Niño , Infecciones por Chlamydia/epidemiología , Infecciones por Chlamydophila/epidemiología , Chlamydophila pneumoniae/genética , Humanos , Japón/epidemiología , Mycoplasma pneumoniae/genética , Neumonía por Mycoplasma/epidemiología , Prevalencia , Estaciones del AñoRESUMEN
Chlamydophila pneumoniae is an intracellular pathogen responsible for respiratory tract infections. The isolation of the microorganism from clinical specimens is essential for a diagnosis. However, the identification of C. pneumoniae by cell cultures is very difficult besides strongly depending on the sample conditions. The study aimed to investigate, in adult patients with pharyngotonsillitis, the frequency of Chlamydophila pneumoniae detection by cell cultures and three conventional PCRs (a conventional PCR targeting the 16S rRNA gene and two nested PCRs, targeting the 16S rRNA gene and the ompA gene, respectively). The presence of chlamydial inclusion in cell cultures was observed in 11/94 samples (11.70%) by IFA. C. pneumoniae DNA was detected in 12/94 (12.76%) specimens by the 16S rRNA gene nested PCR, 4/94 (4.26%) by ompA gene nested PCR, and in 2/94 (2.13%) by 16S rRNA single-step PCR. Our data show poor agreement between the three applied DNA-amplification methods; in fact, only 16S rRNA gene nested PCR showed a statistically significant difference. Moreover, this result allowed us to achieve a definitive confirmation of the previous finding and to avoid the risk of an overestimation of the C. pneumoniae as a pathogen in pharyngotonsillitis.
Asunto(s)
Tonsila Faríngea , Técnicas de Cultivo de Célula , Chlamydophila pneumoniae , Técnicas Microbiológicas , Reacción en Cadena de la Polimerasa , Tonsilitis , Tonsila Faríngea/microbiología , Adulto , Chlamydophila pneumoniae/genética , ADN Bacteriano/genética , Técnicas de Diagnóstico del Sistema Respiratorio/normas , Humanos , Técnicas Microbiológicas/métodos , Técnicas Microbiológicas/normas , Reacción en Cadena de la Polimerasa/normas , ARN Ribosómico 16S/genética , Sensibilidad y Especificidad , Tonsilitis/microbiologíaRESUMEN
Chlamydia pneumonia (C.pn) is a common respiratory pathogen that is involved in human cardiovascular diseases and promotes the development of atherosclerosis in hyperlipidemic animal models. C.pn reportedly up-regulated lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells. Recently, the anti-atherosclerotic activity of peroxisome proliferator-activated receptor γ (PPARγ) has been documented. In the present study, we investigated the effect of C.pn on LOX-1 expression in human umbilical vein endothelial cells (HUVECs) and identified the involvement of the PPARγ signaling pathway therein. The results showed that C.pn increased the expression of LOX-1 in HUVECs in a dose- and time-dependent manner. C.pn-induced up-regulation of LOX-1 was mediated by ERK1/2, whereas p38 MAPK and JNK had no effect on this process. C.pn induced apoptosis, inhibited cell proliferation, and decreased the expression PPARγ in HUVECs. Additionally, LOX-1 activity and cell injury caused by C.pn through activation of ERK1/2 was completely inhibited by rosiglitazone, a PPARγ agonist. In conclusion, we inferred that activation of PPARγ in HUVECs suppressed C.pn-induced LOX-1 expression and cell damage by inhibiting ERK1/2 signaling.
Asunto(s)
Aterosclerosis/genética , Enfermedades Cardiovasculares/genética , PPAR gamma/genética , Receptores Depuradores de Clase E/genética , Apoptosis/genética , Aterosclerosis/microbiología , Aterosclerosis/patología , Enfermedades Cardiovasculares/microbiología , Enfermedades Cardiovasculares/patología , Proliferación Celular/genética , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/patogenicidad , Regulación de la Expresión Génica/genética , Células Endoteliales de la Vena Umbilical Humana/microbiología , Humanos , Sistema de Señalización de MAP Quinasas/genética , PPAR gamma/agonistas , Rosiglitazona/farmacología , Transducción de Señal/efectos de los fármacos , Venas Umbilicales/metabolismo , Venas Umbilicales/patología , Proteínas Quinasas p38 Activadas por Mitógenos/genéticaRESUMEN
OBJECTIVES: Chlamydia pneumoniae is a difficult to diagnose respiratory pathogen. This study was performed to systematically characterize humoral immune responses to selected C. pneumoniae antigens in order to provide novel serodiagnostic perspectives for clinical and epidemiological issues. METHODS: Based on a literature search, gene library screening, and serological proteome analysis, 15 immunogenic surface-associated, virulence-associated, and hypothetical C. pneumoniae antigens were selected, recombinantly expressed, and lined on a nitrocellulose strip. Specific IgM and IgG reactivity was measured in a total of 172 PCR- and micro-immunofluorescence testing (MIF)-characterized serum samples from patients with respiratory infections. A theoretical model was conceived to approximate a putative course of C. pneumoniae antigen expression and assess the potential of early and late antigens. RESULTS: While surface antigens performed poorly, the virulence-associated TARP was a reliable antigen for IgM detection, with a sensitivity of 80.0% and a diagnostic specificity of 90.2%. The hypothetical protein YwbM proved powerful for IgG detection with MIF-correlative sensitivities of up to 94.4% and a diagnostic specificity of 95.1%. CONCLUSIONS: This study provides new insights into antibody profiles to immunogenic proteins in C. pneumoniae infection. The study findings offer antigen candidates for more reliable and standardized serological investigations of C. pneumoniae infections, including studies on seroprevalence and epidemiology.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/inmunología , Infecciones por Chlamydia/inmunología , Chlamydophila pneumoniae/inmunología , Proteínas Bacterianas/genética , Proteínas Bacterianas/inmunología , Infecciones por Chlamydia/diagnóstico , Chlamydophila pneumoniae/genética , Femenino , Humanos , Inmunidad Humoral , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Proteínas Recombinantes/inmunología , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/inmunología , Pruebas Serológicas , Adulto JovenRESUMEN
Respiratory tract infections (RTIs) are severe acute infectious diseases, which require the timely and accurate identification of the pathogens involved so that the individual treatment plan can be selected, including optimized use of antibiotics. However, high throughput and ultrasensitive quantification of multiple nucleic acids is a challenge in a point of care testing (POCT) device. Methods: Herein, we developed a 2×3 microarray on a lateral flow strip with surface enhanced Raman scattering (SERS) nanotags encoding the nucleic acids of 11 common RTI pathogens. On account of the signal magnification of encoded SERS nanotags in addition to the high surface area to volume ratio of the nitrocellulose (NC) membrane, rapid quantification of the 11 pathogens with a broad linear dynamic range (LDR) and ultra-high sensitivity was achieved on one lateral flow microarray. Results: The limit of detection (LOD) for influenza A, parainfluenza 1, parainfluenza 3, respiratory syncytial virus, coxiella burnetii, legionella pneumophila, influenza B, parainfluenza 2, adenovirus, chlamydophila pneumoniae, and mycoplasma pneumoniae were calculated to be 0.031 pM, 0.030 pM, 0.038 pM, 0.038 pM, 0.040 pM, 0.039 pM, 0.035 pM, 0.032 pM, 0.040 pM, 0.039 pM, and 0.041 pM, respectively. The LDR of measurement of the target nucleic acids of the eleven RTI pathogens were 1 pM-50 nM, which span 5 orders of magnitude. Conclusions: We anticipate this novel approach could be widely adopted in the early and precise diagnosis of RTI and other diseases.
Asunto(s)
Nanopartículas del Metal/química , Análisis por Micromatrices/métodos , Técnicas de Diagnóstico Molecular/métodos , Infecciones del Sistema Respiratorio/microbiología , Espectrometría Raman/métodos , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/patogenicidad , Colodión/química , Coxiella burnetii/genética , Coxiella burnetii/patogenicidad , Oro/química , Humanos , Legionella pneumophila/genética , Legionella pneumophila/patogenicidad , Límite de Detección , Análisis por Micromatrices/normas , Técnicas de Diagnóstico Molecular/normas , Mycoplasma pneumoniae/genética , Mycoplasma pneumoniae/patogenicidad , Oligonucleótidos/química , Orthomyxoviridae/genética , Orthomyxoviridae/patogenicidad , Pruebas en el Punto de Atención/normas , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/virología , Espectrometría Raman/normasRESUMEN
BACKGROUND: Acute respiratory infections (ARIs) represent an important cause of morbidity and mortality in children, remaining a major public health concern, especially affecting children under 5 years old from low-income countries. Unfortunately, information regarding their epidemiology is still limited in Peru. METHODS: A secondary data analysis was performed from a previous cross-sectional study conducted in children with a probable diagnosis of Pertussis from January 2010 to July 2012. All samples were analyzed via Polymerase Chain Reaction (PCR) for the following etiologies: Influenza-A, Influenza-B, RSV-A, RSV-B, Adenovirus, Parainfluenza 1 virus, Parainfluenza 2 virus, Parainfluenza 3 virus, Mycoplasma pneumoniae and Chlamydia pneumoniae. RESULTS: A total of 288 patients were included. The most common pathogen isolated was Adenovirus (49%), followed by Bordetella pertussis (41%) from our previous investigation, the most prevelant microorganisms were Mycoplasma pneumonia (26%) and Influenza-B (19.8%). Coinfections were reported in 58% of samples and the most common association was found between B. pertussis and Adenovirus (12.2%). CONCLUSIONS: There was a high prevalence of Adenovirus, Mycoplasma pneumoniae and other etiologies in patients with a probable diagnosis of pertussis. Despite the presence of persistent cough lasting at least two weeks and other clinical characteristics highly suspicious of pertussis, secondary etiologies should be considered in children under 5 years-old in order to give a proper treatment.
Asunto(s)
Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/virología , Tos Ferina/etiología , Infecciones por Adenoviridae/epidemiología , Infecciones por Adenoviridae/etiología , Bordetella pertussis/genética , Bordetella pertussis/aislamiento & purificación , Preescolar , Infecciones por Chlamydophila/epidemiología , Infecciones por Chlamydophila/etiología , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/aislamiento & purificación , Tos/microbiología , Estudios Transversales , Femenino , Hospitalización , Humanos , Lactante , Recién Nacido , Gripe Humana/epidemiología , Gripe Humana/etiología , Masculino , Mycoplasma pneumoniae/aislamiento & purificación , Virus de la Parainfluenza 3 Humana/genética , Virus de la Parainfluenza 3 Humana/aislamiento & purificación , Perú/epidemiología , Neumonía por Mycoplasma/epidemiología , Neumonía por Mycoplasma/microbiología , Infecciones del Sistema Respiratorio/epidemiología , Infecciones por Respirovirus/epidemiología , Infecciones por Respirovirus/etiología , Tos Ferina/diagnóstico , Tos Ferina/epidemiologíaRESUMEN
Chlamydia pneumoniae is one of the two major species of the Chlamydiaceae family that have a profound effect on human health. C. pneumoniae is linked to a number of severe acute and chronic diseases of the upper and lower respiratory tract including pneumonia, asthma, bronchitis and infection by the pathogen might play a role in lung cancer. Following adhesion, Chlamydiae secrete effector proteins into the host cytoplasm that modulate the actin cytoskeleton facilitating internalization and infection. Members of the conserved TarP protein family comprise such effector proteins that polymerize actin, and in the case of the C. trachomatis TarP protein, has been shown to play a critical role in pathogenesis. In a previous study, we demonstrated that, upon bacterial invasion, the C. pneumoniae TarP family member CPn0572 is secreted into the host cytoplasm and recruits and associates with actin via an actin-binding domain conserved in TarP proteins. We have now extended our analysis of CPn0572 and found that the CPn0572 actin binding and modulating capability is more complex. With the help of the fission yeast system, a second actin modulating domain was identified independent of the actin binding domain. Microscopic analysis of HEp-2 cells expressing different CPn0572 deletion variants mapped this domain to the C-terminal part of the protein as CPn0572536-755 binds F-actin in vitro and colocalizes with aberrantly thickened actin cables in vivo. Finally, microscopic and bioinformatic analysis revealed the existence of a vinculin binding sequence in CPn0572. Our findings contribute to the understanding of the function of the TarP family and underscore the existence of several actin binding domains and a vinculin binding site for host actin modulation.